HER2-mTOR signaling–driven breast cancer cells require ER-associated degradation to survive
出版年份 2015 全文链接
标题
HER2-mTOR signaling–driven breast cancer cells require ER-associated degradation to survive
作者
关键词
-
出版物
Science Signaling
Volume 8, Issue 378, Pages ra52-ra52
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2015-05-27
DOI
10.1126/scisignal.aaa6922
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Predicting Cancer-Specific Vulnerability via Data-Driven Detection of Synthetic Lethality
- (2014) Livnat Jerby-Arnon et al. CELL
- Mitogen-activated protein kinase (MAPK) phosphatase-3 (MKP-3) displays a p-JNK-MAPK substrate preference in astrocytes in vitro
- (2014) Christian Ndong et al. NEUROSCIENCE LETTERS
- ER stress-induced cell death mechanisms
- (2013) Renata Sano et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Epidermal growth factor receptor targeting in cancer: A review of trends and strategies
- (2013) Chetan Yewale et al. BIOMATERIALS
- Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress
- (2013) R. M. Young et al. GENES & DEVELOPMENT
- Inconsistency in large pharmacogenomic studies
- (2013) Benjamin Haibe-Kains et al. NATURE
- Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
- (2013) Paola Magnaghi et al. Nature Chemical Biology
- Targeting the unfolded protein response in disease
- (2013) Claudio Hetz et al. NATURE REVIEWS DRUG DISCOVERY
- A comparative survey of functional footprints of EGFR pathway mutations in human cancers
- (2013) A Lane et al. ONCOGENE
- NetWalker: a contextual network analysis tool for functional genomics
- (2012) Kakajan Komurov et al. BMC GENOMICS
- Control of Tumor Bioenergetics and Survival Stress Signaling by Mitochondrial HSP90s
- (2012) Young Chan Chae et al. CANCER CELL
- TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
- (2012) Anurag Singh et al. CELL
- The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer
- (2012) Madhu S. Kumar et al. CELL
- Cleaning Up: ER-Associated Degradation to the Rescue
- (2012) Jeffrey L. Brodsky CELL
- Cancer Vulnerabilities Unveiled by Genomic Loss
- (2012) Deepak Nijhawan et al. CELL
- β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
- (2012) Joseph Rosenbluh et al. CELL
- ER stress–mediated autophagy promotes Myc-dependent transformation and tumor growth
- (2012) Lori S. Hart et al. JOURNAL OF CLINICAL INVESTIGATION
- The glucose-deprivation network counteracts lapatinib-induced toxicity in resistant ErbB2-positive breast cancer cells
- (2012) Kakajan Komurov et al. Molecular Systems Biology
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- Passenger deletions generate therapeutic vulnerabilities in cancer
- (2012) Florian L. Muller et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- The unfolded protein response: controlling cell fate decisions under ER stress and beyond
- (2012) Claudio Hetz NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies
- (2012) B Luo et al. ONCOGENE
- Improving Treatment of HER2-Positive Cancers: Opportunities and Challenges
- (2012) H. M. Stern Science Translational Medicine
- Resisting Targeted Therapy: Fifty Ways to Leave Your EGFR
- (2011) Paul Workman et al. CANCER CELL
- Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven Tumors
- (2011) Thomas De Raedt et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Quantitative Cell-based Protein Degradation Assays to Identify and Classify Drugs That Target the Ubiquitin-Proteasome System
- (2011) Tsui-Fen Chou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cancer therapy based on oncogene addiction
- (2011) Frank McCormick JOURNAL OF SURGICAL ONCOLOGY
- Defining human ERAD networks through an integrative mapping strategy
- (2011) John C. Christianson et al. NATURE CELL BIOLOGY
- Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways
- (2011) T.-F. Chou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer
- (2011) H. W. Cheung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The dual-specificity MAP kinase phosphatases: critical roles in development and cancer
- (2010) O. Bermudez et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments
- (2010) James H Bullard et al. BMC BIOINFORMATICS
- The CrebA/Creb3-like transcription factors are major and direct regulators of secretory capacity
- (2010) Rebecca M. Fox et al. JOURNAL OF CELL BIOLOGY
- International network of cancer genome projects
- (2010) Thomas J. Hudson (Chairperson) et al. NATURE
- The ERAD Inhibitor Eeyarestatin I Is a Bifunctional Compound with a Membrane-Binding Domain and a p97/VCP Inhibitory Group
- (2010) Qiuyan Wang et al. PLoS One
- Use of Data-Biased Random Walks on Graphs for the Retrieval of Context-Specific Networks from Genomic Data
- (2010) Kakajan Komurov et al. PLoS Computational Biology
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells
- (2009) T. W. Miller et al. CLINICAL CANCER RESEARCH
- Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages
- (2009) Gabriela Molina et al. Nature Chemical Biology
- HMG-CoA reductase inhibitors activate the unfolded protein response and induce cytoprotective GRP78 expression
- (2008) Jui-Ching Chen et al. CARDIOVASCULAR RESEARCH
- Inhibition of p97-dependent Protein Degradation by Eeyarestatin I
- (2008) Qiuyan Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started